CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- 4 Open-market buy Director bought 70,000 shares at $1.06 ($74,200)
- 4 Open-market buy Director bought 20,000 shares at $1.04 ($20,800)
- 4 Open-market buy Director bought 30,000 shares at $1.06 ($31,800)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 50,000 shares at $0.52 ($25,995)
- 4/A Other disposition Director disposed of 4,505,941 shares (other)
- 4 Open-market buy Director bought 12,500 shares at $0.51 ($6,375)
- 4 Open-market buy Director bought 25,000 shares at $0.52 ($13,000)
- 4 Open-market buy PRESIDENT AND CEO bought 3,000 shares at $0.51 ($1,530)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 60,000 shares at $0.53 ($31,800)
- 4/A Other disposition Director disposed of 4,505,941 shares (other)
- 4 Other disposition Director disposed of 4,372,497 shares (other)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,951 shares (to pay taxes)
Page 3 of 19 · 371 filings